France's Cellectis Accuses Precision Of Infringement
A French genome-engineering company has alleged that an American biotech is infringing two patents related to materials used to make genome modifications in certain types of organisms, predominantly plants....To view the full article, register now.
Already a subscriber? Click here to view full article